|
Fever Dreams
Greetings on a rainy Sunday morning. I am recovering from quite a week. After our wonderful Lombardi Gala, the week then was highlighted by the exciting receipt of our Notice of Grant Award for our CCSG. It was expected, but it still felt pretty terrific, I must say.
Read more.
| |
Georgetown Lombardi Awarded Top Designation by Federal Government | |
|
The National Cancer Institute (NCI) awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown Lombardi in recognition of its high-impact research, community outreach and cancer care. This designation, awarded by way of a competitive, rigorous, peer-reviewed “cancer center support grant,” was first received by the cancer center 50 years ago. In addition, Hackensack Meridian Health’s John Theurer Cancer Center was renewed by the NCI as Georgetown Lombardi’s research consortium partner. Read more about this news.
| |
At 36th Annual Lombardi Gala, Friends Help Push Boundaries | |
|
A community of nearly 500 new and longtime friends donned gowns and black ties for this year’s annual Lombardi Gala, Georgetown Lombardi’s largest continuous fundraising event. The April 27 event, held at The Anthem in Washington, raised more than $1.25 million in support of the cancer center’s research. Read more about this event.
| |
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity | |
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, Candice Mainor, MD and Barry Hudson, PhD. They outlined their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA. Read more about what they wrote. | |
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40 | |
|
Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, was senior author of a study informing the updated final recommendation of the United States Preventive Services Task Force regarding breast cancer screening, which were released April 30. Read more about this research.
| |
Marshall Honored as a ‘Giants of Cancer Care’ Inductee | |
|
John L. Marshall, MD, Georgetown Lombardi associate director for clinical operations and director of the Ruesch Center for the Cure of Gastrointestinal Cancer, was honored as the inductee in gastrointestinal cancer for the 12th-annual Giants of Cancer Care program, which celebrates the achievements of leading researchers and educators whose discoveries have propelled the field forward and laid the groundwork for future advances. Marshall was one of 15 finalists selected by a group of peer oncologists. He will be honored at an awards ceremony on Thursday, May 30, at the Adler Planetarium in Chicago, Illinois. The Giants of Cancer Care program is presented by OncLive. Read more about this honor.
| |
|
DEADLINE PENDING: Nominate a Candidate for the 2025
Pew-Stewart Scholars Program for Cancer Research Award
| |
|
Georgetown University has been invited to nominate a candidate for the 2025 Pew-Stewart Scholars Program for Cancer Research award. This award supports assistant professors who demonstrate outstanding promise as contributors in science relevant to the field of cancer. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied cancer research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply. View full award eligibility details.
Applicants should submit their nomination package using this portal by Tuesday, May 7, at 11:59 p.m. Questions? Contact Dr. Becca Riggins, rbr7@georgetown.edu.
| |
|
On Thursday, May 30, from 8:30 a.m. - 4:00 p.m.,the Symposium on Applied Immunological Research at 3i will cover the current advances in cellular immunotherapy of cancer. This year’s keynote speaker is Carl H. June, MD, Richard W. Vague Professor in Immunotherapy Professor of Pathology and Laboratory Medicine in Medicine (Hematology-Oncology), Penn Medicine. View agenda and speaker bios. Join this symposium in-person in the Main Auditorium, Center for Discovery and Innovation, Nutley, NJ, with Zoom option available. Register. (+Google Calendar)
| |
Georgetown Lombardi DEI Updates | | |
DEI Office Internship Provides Career-Affirming Experiences for School of Health Student | |
|
|
Lombardi DEI Office intern Lauren Massie presented a poster summarizing her work on the 2024 Lombardi Landscape Diversity Survey at a recent event. Attendees included School of Health Dean Christopher King, PhD, and Lombardi DEI Associate Director Kristi Graves, PhD (pictured).
Lauren joined the office for the final year of her bachelor's in health care management & policy in the School of Health. She offered valuable contributions to the design of the survey, which will be launched soon. She plans to pursue her master’s in health policy at Johns Hopkins University in the fall.
“This internship allowed me to embrace and enjoy supporting the diversity of an organization,” she said. “I enhanced my research skills in investigating best practices for conducting DEI surveys and deciding on demographic questions. I also participated in stakeholder meetings and made connections about the importance of DEI work at Lombardi.” Read more about Lauren's experience.
| |
|
Cancer Research Data Meeting
Thursday, May 9
9:00 - 10:00 a.m.
Christopher Priestley-Milianta, an MD/PhD student in the Tumor Biology Program, presents “αCD38 Combination with αPD-1 Therapy in Solid Tumors: New Hope From Prior Failures.” Mentor: Samir Khleif, MD. Join the meeting in W302 or via Zoom. (+Google Calendar)
| |
|
Real-time Identification of Invasive Cancer Cell Interactions
Thursday, May 16
11:00 a.m.
Georgetown’s Ghada Sharif, PhD, Anton Wellstein, MD, PhD, and Makarand Paranjape, PhD, discuss the complex world of tumor growth and its dynamic interplay with stromal cells and demonstrate the capabilities of the capabilities of the Agilent xCELLigence RTCA Cell Invasion and Migration Plate (CIM-plate), designed to facilitate real-time detection and precise isolation of invasive cancer cell subpopulations within heterogeneous tumor mixtures. Register for this webinar.
| |
|
Special Seminar: “What Makes a Successful Implementation Research Grant Proposal?”
Friday, May 17
12:00 to 1:00 p.m.
Hear from past and present NIH Study Section Chairs of the Science for Implementation in Health and Healthcare (SIHH) on what makes a successful implementation research grant proposal. Featuring Stephen Bartels, MD, MS (Mongan Institute, Massachusetts General Hospital and Harvard Medical School); Heather M. Brandt, PhD (St. Jude Children’s Research Hospital and St. Jude Comprehensive Cancer Center); and Jeremiah R. Brown, PhD, MS (Dartmouth Center for Implementation Science). Hosted by the Georgetown Lombardi Cancer Prevention & Control Program, Cancer Care & Delivery Working Group. Join this presentation in 2115 Wisconsin Avenue, Room G313, Lower Level or via Zoom. (+Google Calendar)
| |
Funding and Award Opportunities | |
|
NEW 2024 Call for V Scholar Cancer Research Grant Applications
The V Scholar Award supports young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. This RFA is specifically for adult cancer research. The V Foundation has a fundraising focus on colorectal cancer in 2024 and welcomes proposals in this area, but this is not required. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research. We strongly encourage applications from those who identify as a member of an underrepresented in science minority racial or ethnic group. The total amount of the grant is $600,000, paid in three annual installments of $200,000. View full RFA. Those interested in applying should submit a one-page letter of intent to Sharon Levy (sgl5@georgetown.edu) by Friday, May 17, COB. Completed Nomination Form, Letter of Recommendation, and Financial Worksheet due May 29; applications due July 1.
| |
|
NEW Small Business Transition Grant for Academic Biotech Innovators
The Small Business Transition Grant is accepting applications from early career scientists seeking support in their pursuit of taking their cancer technologies from research institutions into a startup to advance their biotech inventions toward commercialization. This fast-track opportunity provides up to a total of ~$2.5 million for projects that fit into one of the following categories:
- Therapeutics and preventive agents
- Imaging technologies, interventional devices, and in vivo diagnostics
- In vitro and ex vivo diagnostics and prognostics
- Technologies for cancer prevention and control, supportive care, and survivorship
Those interested in applying should submit a letter of intent to NCI SBIR Program Director Saroj Regmi (saroj.regmi@nih.gov) by Sunday, July 21. Learn more about this funding opportunity at informational webinar on Tuesday, May 21, at 2:00 p.m. ET. Attendees will receive a detailed overview of the Small Business Transition Grant, followed by a Q&A session with presenters. Register.
| |
|
Spring 2024 ASPIRE Award: Breaking Ground in Targeting Gastric and Esophageal Tumors
This request for proposals from the Mark Foundation for Cancer Research, DeGregorio Family Foundation and Torrey Coast Foundation is for projects focused on tumors of the upper GI tract. Proposals should aim to drive disruptive research, with the goal of advancing the field of gastric and esophageal cancer research and ultimately improving patient outcomes. Interdisciplinary collaborations are encouraged and independent investigators at all career stages, especially those new to the field of upper GI cancers, are welcome to apply. Awards are $250,000 total over a 12-month term, beginning fall 2024. LOI deadline: Monday, May 27, at 5:00 p.m. ET. View full guidelines and link to the submission portal.
| |
|
RADIANCE Grants Request for Proposals and Information Sessions
The Georgetown University Center for Health Equity and GUMC Office of Faculty and Academic Affairs announce the second round of RADIANCE Grants (Respect, Advocacy, Diversity, Inclusion, ANti-racism, Collaboration, Equity). These RADIANCE Grants aim to contribute to community engagement that centers a culture of respect, inclusion and belonging through strategies that promote advocacy, diversity, anti-racism and equity. View the Request for Proposals for information including application and review processes. Deadline for proposal submission: Friday, May 31, at 11:59 p.m. ET. Online information sessions about the program take place 5/6, 5:00 - 6:00 p.m. and 5/15, 4:00 - 5:00 p.m. RSVP to attend. Email questions to ofaa@georgetown.edu.
| |
2024 Federal Lung Cancer Funding Opportunities
The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2024 funding opportunities. The LCRP looks to support highly innovative, high-risk early ideas, advanced translation research, early stage clinical trials and patient-centered outcomes and survivorship research. In addition, it supports researcher development with a career development-focused award mechanism. Pre-application (letter of intent/preproposal) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Career Development Award: LOI due May 28, 5:00 p.m. ET
-
Concept Award: LOI due May 28, 5:00 p.m. ET
-
Idea Development Award: Preproposal due May 28, 5:00 p.m. ET
-
Translational Research Award: Preproposal due May 28, 5:00 p.m. ET
-
Patient-Centered Outcomes and Survivorship Award: LOI due July 17, 5:00 p.m. ET
| |
|
Phi Beta Psi Grant Proposal Invitation
The goal of the Phi Beta Psi Charity Trust is to advance cancer research nationwide to improve prevention, diagnosis and treatment by providing research grants to qualified investigators addressing original questions and hypotheses to be explored in basic and clinical studies in the field of cancer. Research applications must be focused on brain, breast, colorectal, endometrial, lung, ovarian, pancreatic or prostate cancer. Preference is given to young investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems. Applications from established investigators exploring new and innovative areas of cancer research also will be considered. Postdoctoral fellows are not eligible. Two proposals from Georgetown Lombardi will be considered. View full application information. Direct questions to Kelli Lozada Reese, pbp.2vp@gmail.com. Applications for grants must be submitted electronically as well as mailed to the office of the National Second Vice President by Monday, June 10.
| |
|
Multiple Myeloma Research Foundation Research Fellows Award Program
The Multiple Myeloma Research Foundation (MMRF) Research Fellows Award Program is an initiative that supports early career researchers at the postdoctorate, medical fellow or junior faculty levels currently active or interested in research in multiple myeloma research. The MMRF will provide $150,000 in research funding over two years to successful applicants who seek to learn more about the biology of multiple myeloma and identify new approaches to monitor for and treat the disease. Read the full program guidelines. Application deadline is Friday June 28, at 11:59 p.m. ET; applications must be submitted via ProposalCENTRAL.
| |
|
Federal Grants Digest: Colleges & Universities Edition
A weekly curated digest of federal funding opportunities of interest to colleges and universities to support programming, research, infrastructure and other efforts, provided by Thorn Run Partners. View current issue (for May 1, 2024).
| |
Meetings in italics should be attended by all fellows.
| |
|
8:00 AM | Division Weekly Update Meeting | Podium A / Microsoft Teams
8:30 AM | Monday Morning Oncology Report | Inpatient Oncology Fellow | Podium A / Microsoft Teams
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528 212 194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796 253 566)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869 742 463)
| |
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
4:00 PM | Liver Tumor Board | Microsoft Teams
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 932 1012 3816; CME Code: 87253)
| |
|
8:00 AM | Thoracic Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 993 7680 5192; Passcode: 4231; CME 86693)
12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams (CME: 80988)
5:00 PM | GI Tumor Board | Podium A / Microsoft Teams
| |
|
9:00 AM | Cancer Research Data Meeting - Christopher Priestley-Milianta: “αCD38 Combination with αPD-1 Therapy in Solid Tumors: New Hope From Prior Failures” | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board | Microsoft Teams
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
5:00 PM | Lymphoma Tumor Board - every other week | Microsoft Teams
5:00 PM | Myeloma Tumor Board - every other week | Microsoft Teams
| |
|
7:00 AM | CNS Tumor Board | Microsoft Teams (Meeting ID: 298 285 483 265, Passcode: rJWpmU)
12:00 PM | Oncology Grand Rounds Lecture Series | none | New Research Building Auditorium / Zoom
12:00 PM | Dr. Tara Berman (DFCI) - Gyn – Cervical Cancer | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)
1:00 PM | Dr. Jeremy Abramson (MGH) - DLBCL | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)
1:00 PM | Pancreas Tumor Board | Microsoft Teams (Meeting ID: 299 996 740 910, Passcode: z7j7Rc)
2:00 PM | Faculty Evaluations | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)
| |
Connect with Georgetown Lombardi on Social Media | |
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. | | | | |
